CMS Not Likely to Restrict Coverage of Drug-Eluting StentsCMS Not Likely to Restrict Coverage of Drug-Eluting Stents

A CMS official told those at TCT 2007 that the agency is unlikely to scale back coverage for drug-eluting stents, even in the wake of safety concerns, the Wall Street Journal reports. In February, CMS said it was considering restricting coverage for off-label uses of the products.